Chapter 5: Drugs affecting the uterine motility
Oxytocin, prostaglandins, ergot alkaloids
Drugs acting on uterine motility
Oxytocin
Ergot alkaloids:
Ergometrine, methylergometrine
Prostaglandins:
PGE2, PGF2α
Miscellaneous:
Ethacridine, quinine
Uterine stimulants
Beta sympathomimetics
Terbutaline, Ritodrine
Calcium channel blockers
Nifedipine
Magnesium sulphate
Prostaglandin inhibiting agents
Indomethacin
Oxytocin antagonist
Atosiban
Uterine relaxants (Tocolytics)
Role of oxytocin in uterine contraction during labor
cervix,
Role of oxytocin in uterine contraction during labor
The hormone oxytocin regulates myometrial activity, causing uterine contraction.
Baby pushes against cervix, causing it to stretch which causes nerve impulses to be sent to brain hypothalamus.
Oxytocin is released from fetus and mother’s posterior pituitary.
This oxytocin stimulates contraction of uterus. Uterine contraction further stimulates release of more oxytocin from pituitary gland.
Oxytocin also stimulates placenta to make prostaglandins which further cause contraction of the uterus.
Given by slow intravenous infusion to induce labor, oxytocin causes regular coordinated contractions that travel from fundus to cervix.
Role of oxytocin in lactation
Suckling of baby stimulate
hypothalamus to release of oxytocin from posterior pituitary and prolactin from anterior pituitary.
Prolactin acts on milk-making tissue to produce milk for baby.
Oxytocin contracts myoepithelial cells in the mammary gland, which causes ‘milk let-down’- the
expression of milk from the alveoli and ducts.
Oxytocin also makes the milk ducts widen, making it easier for the milk to flow down.
Inducing labor is the artificial start of the birth process through medical interventions or other methods.
Inducing labor
According to the American College of Obstetricians and Gynecologists, labor should be induced only when it is more risky for the baby to remain inside the mother’s uterus than to be born
Postterm pregnancy, i.e. if the pregnancy has gone past the end of the 42nd week
Twin pregnancy continuing beyond 38 weeks.
Premature rupture of the membranes (PROM); this is when the membranes have ruptured, but labor does not start within a specific amount of time
Previous health conditions that puts risk on the woman and/or her child such as diabetes, high blood pressure.
Intrauterine fetal growth restriction (IUGR)
There are health risks to the woman in continuing the pregnancy (pre-eclampsia)
Premature termination of the pregnancy (abortion)
Fetal death in utero and previous history of stillbirth
Medical reasons for induction of labor
Prostaglandin:
Suppositories are inserted into the vagina during the evening causing the
uterus to go into labor by morning. One advantage to this method is that the mother is free to move around the labor room.
Oxytocin:
The body naturally produces the hormone oxytocin to stimulate contractions.
Oxytocin can be given through an IV at low doses to stimulate contractions.
Labor induction methods
1. Medications
Some health care providers might suggest rupturing the amniotic membrane artificially.
When the bag of water (amniotic sac) breaks or ruptures, production of
prostaglandin increases, speeding up contractions.
2. Artificial rupture of the membranes (AROM)
Labor induction methods
A sterile, plastic, thin hook is brushed against the membranes just inside the cervix causing the baby’s head to move down against the cervix, which usually causes the contractions to become stronger. This procedure releases a gush of warm amniotic fluid from the vagina.
Nipple Stimulation is a natural form of labor induction that can be done manually or with an electric breastfeeding pump.
Nipple stimulation induces the production of the hormone oxytocin which causes uterine contractions.
The concept is the same as when a baby nurses right after birth, stimulating contractions, which slows bleeding.
3. Natural:
Labor induction methods
Prostaglandins in uterine motility
The endometrium and myometrium have substantial prostaglandin-synthesising capacity, particularly in the second, proliferative phase of the menstrual cycle.
Prostaglandin F2α (PGF2α) is generated in large amounts, and has been implicated in the ischaemic necrosis of the endometrium that precedes menstruation.
PGE2 and PGI2 are also generated by the uterus.
PGF2α and PGE2 promote coordinated contractions of the body of the pregnant uterus, while relaxing cervix.
Prostaglandins used in obstetrics:
Dinoprostone (PGE2)
Carboprost (PGF2a)
Gemeprost or misoprostol (PGE1 analogues)
A normal pregnancy lasts about 40 weeks. Occasionally, labor begins prematurely, before the 37th week of pregnancy. This happens because uterine contractions cause the cervix to open earlier than normal. Consequently, the baby is born premature and can be at risk for health problem.
Preterm labor
The earlier premature birth happens, the greater the health risks for the baby.
Many premature babies might suffer from long-term mental and physical disabilities.
That’s why they need special care in the neonatal intensive care unit.
The specific cause of preterm labor often isn't clear. However, certain risk factors might increase the risk, but preterm labor can also occur in pregnant women with no known risk factors.
Constant low, dull backache
Mild abdominal cramps
Vaginal spotting or light bleeding
Preterm rupture of membranes
A sensation of pelvic or lower abdominal pressure
Regular or frequent sensations of abdominal tightening (contractions)
A change in type of vaginal discharge — watery, mucus-like or bloody Sign and Symptoms
Preterm labor
Preterm Labor: Risk Factors
Smoking cigarettes or using illicit drugs
Presence of a fetal birth defect
Too much amniotic fluid (polyhydramnios)
Vaginal bleeding during pregnancy
Stressful life events, such as the death of a loved one
An interval of less than six months between pregnancies
Previous preterm labor or premature birth
Pregnancy with twins, triplets or other multiples
Problems with the uterus, cervix or placenta
Certain infections, particularly of the amniotic fluid and lower genital tract
Some chronic conditions, such as high blood pressure and diabetes
Medications
Once a pregnant woman is in labor, there are no medications or surgical procedures to stop labor.
However, the doctor might recommend the following medications:
Preterm labor
Tocolytics might be given to temporarily stop uterine contractions.
However, these medications won't halt preterm labor for longer than two days because they don't address the underlying cause of preterm labor.
Tocolytics might delay preterm labor long enough for corticosteroids to
provide the maximum benefit or, if necessary, for patient to be transported to a facility that can provide specialized care for the premature baby.
Tocolytics
Tocholytics
Magnesium sulphate
Prostaglandin inhibiting agents o Indomethacin
Oxytocin antagonist: Atosiban
Beta sympathomimetics o Terbutaline , Ritodrine
Calcium channel blockers: Nifedipine
The elevation of cellular Ca2+ promotes contraction via the Ca2+/calmodulin-dependent activation of myosin light chain kinase (MLCK).
Relaxation is promoted by the elevation of cyclic nucleotides (cAMP and cGMP) and their activation of protein kinases, which cause phosphorylation/inactivation of MLCK.
Pharmacological manipulations to reduce myometrial contraction include:
o Inhibiting Ca+2 entry (Ca2+ channel blockers, MgSO4) o Reducing mobilization of intracellular Ca2+ by
- antagonizing GPCR-mediated activation of Gq-PLC-IP3-Ca2+ pathway - reducing production of the PGF2α (with COX inhibitors)
- antagonizing prostaglandin and oxytocin receptors
o Enhancing relaxation by elevating cellular cAMP (with β2 adrenergic agonists
enhancing Gs-AC) and cyclic GMP (with NO donors that stimulate guanylyl cyclase)
Mechanism of action of tocholytic drugs
Mechanism of action of tocholytic drugs
1 2
6 5
4 3
Magnesium sulfate might be prescribed if the woman has a high risk of delivering baby between 24 and 32 weeks of pregnancy.
In the United States, IV magnesium sulfate has become the most commonly used drug for treating preterm labor.
Some research has shown that magnesium sulfate therapy might reduce the risk of a specific type of damage to the brain (cerebral palsy) for babies born before 32 weeks of gestation.
Magnesium sulfate is thought to trigger cerebral vasodilation, thus reducing ischemia generated by cerebral vasospasm during an eclamptic event.
Magnesium sulfate as tocolytics in preterm